The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation

References

• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 1347
   PubMed Web of Science ®Google Scholar
• Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871 - 874
   PubMed Web of Science ®Google Scholar
• Beranger F, Mange A, Goud B, Lehmann S. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells. J Biol Chem 2002; 277:38972 - 38977
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling and reduces prion formation. J Biol Chem 2011; 286:8752 - 8758
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Mayor S. The GPI-anchor and protein sorting. Cell Mol Life Sci 2001; 58:1969 - 1987
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435 - 1439
   PubMed Web of Science ®Google Scholar
• McNally KL, Ward AE, Priola SA. Cells expressing anchorless prion protein are resistant to scrapie infection. J Virol 2009; 83:4469 - 4475
   PubMed Web of Science ®Google Scholar
• Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, et al. Intercellular transfer of the cellular prion protein. J Biol Chem 2002; 277:47671 - 47678
   PubMed Web of Science ®Google Scholar
• Sotgia F, Razani B, Bonuccelli G, Schubert W, Battista M, Lee H, et al. Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 2002; 22:3905 - 3926
   PubMed Web of Science ®Google Scholar
• Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 1996; 93:14945 - 14949
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB, et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129:121 - 132
   PubMed Web of Science ®Google Scholar
• Brown DA, London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000; 275:17221 - 17224
   PubMed Web of Science ®Google Scholar
• Schroeder R, London E, Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 1994; 91:12130 - 12134
   PubMed Web of Science ®Google Scholar
• Huang J, Feigenson GW. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys J 1999; 76:2142 - 2157
   PubMed Web of Science ®Google Scholar
• Chang TY, Chang CCY, Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Ann Rev Biochem 1997; 66:613 - 638
   PubMed Web of Science ®Google Scholar
• Nichols B. Endocytosis of lipid-anchored proteins: excluding GEECs from the crowd. J Cell Biol 2009; 186:457 - 459
   PubMed Web of Science ®Google Scholar
• Farooqui AA, Horrocks LA, Farooqui T. Deacylation and reacylation of neural membrane glycerophospholipids. J Mol Neurosci 2000; 14:123 - 135
   PubMed Web of Science ®Google Scholar
• Bate C, Tayebi M, Williams A. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication. Biochem J 2010; 428:95 - 181
   PubMed Web of Science ®Google Scholar
• Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 2004; 378:281 - 292
   PubMed Web of Science ®Google Scholar
• Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJT, Gill AC. Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 2010; 285:9868 - 9880
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 1135
   PubMed Web of Science ®Google Scholar
• Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1:31 - 39
   PubMed Web of Science ®Google Scholar
• Bate C, Tayebi M, Williams A. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation. BMC Biol 2008; 6:8
   PubMed Web of Science ®Google Scholar
• Bate C, Reid S, Williams A. Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. J Biol Chem 2004; 279:36405 - 36411
   PubMed Web of Science ®Google Scholar
• Nalefski EA, Sultzman LA, Martin DM, Kriz RW, Towler PS, Knopf JL, et al. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. J Biol Chem 1994; 269:18239 - 18249
   PubMed Web of Science ®Google Scholar
• Gaudreault SB, Chabot C, Gratton JP, Poirier J. The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity. J Biol Chem 2004; 279:356 - 362
   PubMed Web of Science ®Google Scholar